Aclarion, Inc. (ACONW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-7,371.68 et chiffre d'affaires de $0.00B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-7,480.21 vs est $-7,371.68 (manqué -1.5%). 2025: réel $-13.61 vs est $-15.13 (dépassé +10%). Précision des analystes: 94%.
Estimations du BPA — ACONW
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$7,480.21
vs Est –$7,371.68
▼ 1.5% off
2025
Actual –$13.61
vs Est –$15.13
▲ 11.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Estimations du CA — ACONW
89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 20.3% off
2025
Actual $0.000B
vs Est $0.000B
▼ 1.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Les autres consultent aussi
